• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Becton Dickinson (NY:BDX)

    146.75 +4.40 (+3.09%)
    Streaming Delayed Price Updated: 12:05 PM EDT, May 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Becton Dickinson

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    News headline image
    Becton, Dickinson and Company Q2 Earnings Call Highlights ↗
    Becton, Dickinson and Company (NYSE:BDX) reported fiscal second-quarter revenue and adjusted earnings ahead of its internal expectations, while management raised its full-year adjusted earnings outlook... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Becton Dickinson (BDX) Q2 2026 Earnings Transcript ↗
    Becton Dickinson (BDX) Q2 2026 Earnings Transcript 
    Via The Motley Fool
    Topics Retirement World Trade
    News headline image
    Becton Dickinson Hikes Profit Outlook, Names CFO ↗
    Becton Dickinson (NYSE: BDX) tops Q2 estimates with $4.71B revenue and raises 2026 earnings outlook. New CFO Vitor Roque appointed. 
    Via Benzinga
    What's going on in today's session: S&P500 gap up and gap down stocks ↗
    Via Chartmill
    BDX (Becton Dickinson) Posts EPS Beat in Q2 2026, Pre-Market Rallies Despite Slight Revenue Miss ↗
    Via Chartmill
    News headline image
    BD’s (NYSE:BDX) Q1 CY2026 Sales Beat Estimates
    Medical technology company Becton, Dickinson and Company (NYSE:BDX) announced better-than-expected revenue in Q1 CY2026, with sales up 5.2% year on year to $... 
    Via StockStory
    Topics Earnings
    News headline image
    The Healthcare Stock Built for Investors Who Prioritize Capital Preservation ↗
    This company collects a lot of recurring revenue -- and pays a growing dividend. 
    Via The Motley Fool
    Topics Government
    News headline image
    3 Magnificent Dividend Stocks the Sell-Off Has Put on Sale. Buy Them Now and Hold Forever. ↗
    With these Dividend Kings, the market's pain is your gain. 
    Via The Motley Fool
    News headline image
    3 Healthcare Stocks That Have Held Up in Every Market Downturn ↗
    Johnson & Johnson, Abbott Laboratories, and Becton, Dickinson don't fall as far as other healthcare stocks and bounce back faster during economic downturns. 
    Via The Motley Fool
    Topics Economy
    News headline image
    Inflation Fever Breaks: March PPI Data Offers Unexpected Relief to Markets
    The financial markets received a much-needed breath of fresh air this week as the Bureau of Labor Statistics released the Producer Price Index (PPI) report for March 2026. Final demand prices rose by... 
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    What Makes a Healthcare Stock Worth Holding Through a Recession? ↗
    Not all healthcare stocks are defensive in a downturn. Here's what to consider. 
    Via The Motley Fool
    Topics Economy
    News headline image
    Avanos Medical to be Acquired by American Industrial Partners for $1.27 Billion; Stock Surges 69%
    The medical technology landscape witnessed a seismic shift on Tuesday as Avanos Medical (NYSE: AVNS) announced it has entered into a definitive agreement to be acquired by affiliates of American... 
    Via MarketMinute
    Topics Economy
    News headline image
    Becton Dickinson (BDX) Q4 2024 Earnings Transcript ↗
    Becton Dickinson (BDX) Q4 2024 Earnings Transcript 
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Becton Dickinson (BDX) Q2 2025 Earnings Transcript ↗
    Becton Dickinson (BDX) Q2 2025 Earnings Transcript 
    Via The Motley Fool
    Topics World Trade
    News headline image
    Becton Dickinson (BDX) Q3 2025 Earnings Transcript ↗
    Becton Dickinson (BDX) Q3 2025 Earnings Transcript 
    Via The Motley Fool
    News headline image
    Becton Dickinson (BDX) Q1 2025 Earnings Transcript ↗
    Becton Dickinson (BDX) Q1 2025 Earnings Transcript 
    Via The Motley Fool
    News headline image
    Becton Dickinson (BDX) Q4 2025 Earnings Transcript ↗
    Becton Dickinson (BDX) Q4 2025 Earnings Transcript 
    Via The Motley Fool
    Topics World Trade
    News headline image
    Market Crash: The Healthcare Stocks I'd Buy Without Hesitation ↗
    Don't miss out on these opportunities. 
    Via The Motley Fool
    Topics Economy Stocks World Trade
    News headline image
    The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic Breakup
    Disclaimer: This content is intended for informational purposes only and is not financial advice. Today’s date is April 9, 2026. Introduction In the high-stakes arena of medical technology, few stories... 
    Via Finterra
    Topics Economy World Trade
    News headline image
    The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
    As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (NYSE: BDX). Known... 
    Via Finterra
    Topics Artificial Intelligence
    News headline image
    The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)
    As of April 1, 2026, Becton, Dickinson and Company (NYSE: BDX), commonly known as BD, finds itself at a historic crossroads. For decades, BD was viewed as a diversified healthcare conglomerate—a... 
    Via Finterra
    Topics Economy Lawsuit Product Recall
    News headline image
    3 Large-Cap Stocks with Questionable Fundamentals
    Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit... 
    Via StockStory
    News headline image
    3 Profitable Stocks We Steer Clear Of
    While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
    Via StockStory
    Topics Economy
    News headline image
    3 Reasons BDX is Risky and 1 Stock to Buy Instead
    Over the last six months, BD’s shares have sunk to $160.20, producing a disappointing 14.6% loss while the S&P 500 was flat. This was partly due to its softe... 
    Via StockStory
    Topics Stocks
    News headline image
    3 Healthcare Stocks Walking a Fine Line
    From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realiz... 
    Via StockStory
    News headline image
    2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $1,000 ↗
    This Dividend King is out of favor, and this medical device peer has just introduced an exciting new product. 
    Via The Motley Fool
    News headline image
    Baxter International (BAX) Deep Dive: Navigating the 16% Plunge and a New Strategic Era
    On February 16, 2026, the mood surrounding Baxter International (NYSE: BAX) is one of cautious sobriety following a seismic shift in investor confidence. Long regarded as a defensive staple of the... 
    Via Finterra
    Topics Artificial Intelligence Earnings Economy
    News headline image
    5 Must-Read Analyst Questions From BD’s Q4 Earnings Call
    Becton, Dickinson and Company’s fourth quarter results were shaped by ongoing portfolio transformation, targeted investments in growth platforms, and the headwind of international tariffs. Management... 
    Via StockStory
    Topics Earnings World Trade
    Exploring the top movers within the S&P500 index during today's session. ↗
    Via Chartmill
    News headline image
    Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency
    On February 11, 2026, the clinical laboratory landscape is recalibrating following a whirlwind 48 hours of financial and regulatory news. Quest Diagnostics (NYSE: DGX), the nation’s leading provider of... 
    Via Finterra
    Topics Artificial Intelligence
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.